Celgene Corporation Board of Directors Recommends To Our Stockholders A Two-for-One Stock Split

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ:CELG) announced that the Board of Directors voted to recommend a two-for-one split of the Company’s common stock to be effected through an Amendment to the Company’s Certificate of Incorporation. “This recommendation reflects our continued confidence in the long-term outlook for the Company,” said Bob Hugin, Chairman and Chief Executive Officer of Celgene Corporation.

Help employers find you! Check out all the jobs and post your resume.

Back to news